Dr. Joerg Schlingemann, Merck Healthcare KGaA - Qepler Summits And Conferences

Dr. Joerg Schlingemann

Director, Principal Expert Quality Control Systems
Merck Healthcare KGaA
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across Healthcare, Life Science and Electronics.

Joerg Schlingemann is a director and principal expert for quality control systems within Merck KGaA’s/EMD Serono’s healthcare quality unit.

He studied molecular biology in Uppsala and Heidelberg, where he completed a doctorate degree at the German Cancer Research Center in 2005. He has 14 years of experience in the pharmaceutical industry from various roles within quality control and quality assurance.

Since late 2019, Joerg has been leading EMD Serono’s analytical activities for N-nitrosamines. Joerg is married and has three children.

Related Sessions:

3rd Annual Genotoxic Impurities
in Pharmaceuticals Summit 2023

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 09 Mar 2023
  • Virtual,
  • Pharma
Day 2: Friday, 10 March 2023
CASE STUDY: Case Studies of Nitrosamines in Pharmaceuticals
  • NDMA in Metformin DP
  • Analytical challenges
  • Some NDSRI(s)
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.